SCHEMBL5284239

SCHEMBL5284239

O=C(Oc1c(F)c(F)c(F)c(F)c1F)c1ccc2ncccc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.68
ALOX15 P16050 1/20 0.68
PLK1 P53350 1/20 0.59
DOT1L Q8TEK3 1/20 0.50
ALDH1A1 P00352 6/20 0.49
MAPT P10636 3/20 0.49
RAB9A P51151 4/20 0.48
NPC1 O15118 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
LMNA P02545 1/20 0.47
BCAT1 P54687 1/20 0.46
POLB P06746 2/20 0.46
CYP3A4 P08684 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25294487 0.82 HTT (0.74) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL5281392 0.82 MGAM (0.56) HTTALOX15MAPTRAB9ANPC1
SCHEMBL265015 0.81 ALOX15 (1.00) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL30718649 0.81 ALOX15 (1.00) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL25255693 0.81 HTT (0.72) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL12311610 0.80 ALDH1A1 (0.71) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL27928930 0.80 ALOX15 (0.97) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL31232924 0.79 CES2 (0.52) ALOX15ALDH1A1MAPTRAB9ANPC1
SCHEMBL21816441 0.78 ALOX15 (0.68) HTTALOX15PLK1DOT1LALDH1A1
SCHEMBL828067 0.77 ALOX15 (0.71) HTTALOX15PLK1DOT1LALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 HTT 4781/4885ALOX15 4819/4885PLK1 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.